Followers | 353 |
Posts | 13825 |
Boards Moderated | 5 |
Alias Born | 09/27/2010 |
Thursday, July 21, 2016 3:53:14 PM
Anyone who truly knows what this company is doing, their market, what they are setting up for (lot's of puzzle pieces and once you put them all together using logic, then you'll see), their CEO, etc, wouldn't think about selling all out until much later.
I don't think many on ihub (or 99% of retail people) have a clue of how strong the fundamentals are here and what's is setting up for years to come.
Anything can happen sure. But read all the news the past 2 years and do some serious DD and I bet you'll see what I do.
For all you traders here, do your thing. This thing is bigger than we can imagine.
My input, if you are a trader, is always hold onto free shares as an investment on the house.
I imagine good results on the human trials will send this over $1 and from there I can only assume we'll see distribution partner(s) that imo are in place will be announced, manufacturing will be ready to meet demand, sales teams ready, AKA everything for a full scale launch in Europe will be ready. Then the human trial results on this medical device to be given to the FDA for clearance then a full scale launch in the US.
Through my DD on the market for hemostatic devices leaves me with the assumption (my best guess) that Johnson & Johnson $JNJ may likely be a distribution partner for $ARTH. And/or buy ARTH out for a couple billion dollars. May sound out there to some. Who knows right?
All just my opinion. I know what I own and why.
Stay very disciplined and consistent.
Find what works for you and stick with it.
Identify support/resistance ranges to buy and sell.
Invest in the fundamentals, trade the technicals.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM